|
PROGRAM
Session 1: Genomic Medicine
"The 100,000 genomes project and beyond: mainstreaming genome medicine in the UK National Health Service as a model for use of patient data for both clinical care and research"
Tim Hubbard (King's College London)
"Sequencing and Analysis of 100,000s of Human Genomes"
Goncalo Abecasis (Regeneron)
"Long-read sequencing of disease-associated repeat expansions"
Shinichi Morishita (The University of Tokyo)
Session 2: Genome Regulation
"Title TBD"
Emmanouil (Manolis) Dermitzakis (University of Geneva)
"From genomics to therapeutics: dissection and manipulation of human disease circuitry at single-cell resolution"
Manolis Kellis (MIT)
"Evolving brains with new genes; Human-specific gene NOTCH2NL expands neuronal number in the cerebral cortex"
Ikuo Suzuki (The University of Tokyo)
Plenary: Cancer Genomics
"An Immunogenomic View of Personalized Cancer Medicine"
Thomas Hudson (AbbVie Inc.)
Session 3: Chromatin
"A 3D Code in the Human Genome"
Erez Lieberman Aiden (Baylor College of Medicine)
"Dynamic reorganization of three-dimensional chromosome architecture revealed by single-cell Hi-C"
Takashi Nagano (Osaka University)
Session 4: Single Cell
"Spatial genomics: transcriptome profiling in situ"
Long Cai (California Institute of Technology)
"Landscape of the breast cancer microenvironment at single-cell resolution"
Alex Swarbrick (Garvan Institute of Medical Research)
"DNA barcode technologies to dissect heterogeneous biological systems"
Nozomu Yachie (The University of Tokyo)
Session 5: New Technology
"Using nanopore sequencing to interrogate the genome, epigenome and transcriptome"
Winston Timp (Johns Hopkins University)
Session 6: Genome Editing
"Genome editing approaches for oncology discovery and immune engineering"
Sidi Chen (Yale University)
"Development of High-Throughput Functional Genomics Tools to Study Drug Interactions and Mechanisms of Cellular Uptake"
Michael C. Bassik (Stanford University)
"Molecular mechanism of CRISPR and structure-based development of genome editing tool towards medical applications"
Osamu Nureki (The University of Tokyo)
|
|
|
|